Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.012 CHF | -0.98% | +5.89% | -4.82% |
May. 02 | Idorsia Boosts Consent Fee Offer to 2024 Convertible Bond | MT |
Apr. 26 | Idorsia Gets EU Medicines Regulator's Positive Opinion for Resistant Hypertension Treatment | MT |
Chart calendar Idorsia Ltd
Upcoming events on Idorsia Ltd
Past events on Idorsia Ltd
2024-04-10 | Annual General Meeting |
2024-03-20 10:00 am | TRYVIO FDA Approval Call |
2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
2023-11-13 | Credit Suisse Equity Forum |
2023-10-24 09:00 am | Q3 2023 Earnings Call |
2023-10-24 01:00 am | Q3 2023 Earnings Release |
2023-09-17 | Baader Investment Conference |
2023-09-12 | Bank of America Global Healthcare Conference |
2023-09-10 | Morgan Stanley Global Healthcare Conference |
2023-09-05 | Citi BioPharma Conference |
2023-07-25 09:00 am | Q2 2023 Earnings Call |
2023-07-25 01:00 am | Q2 2023 Earnings Release |
2023-06-28 | Stifel European Healthcare Summit |
2023-06-21 | J.P. Morgan European Healthcare Conference |
2023-06-19 | Citi European Healthcare Conference |
2023-06-11 | Goldman Sachs Global Healthcare Conference |
2023-06-06 | Jefferies Global Healthcare Conference |
2023-05-08 | Bank of America Healthcare Conference |
2023-05-04 03:00 am | Annual General Meeting |
2023-04-25 07:00 am | Q1 2023 Earnings Call |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 61,0 40,9 48.96% | 24,0 36,2 -33.75% | 72,0 73,8 -2.39% | 35,0 39,5 -11.29% | 97,0 79,5 21.99% | 126 |
EBITDA Million CHF | Released Forecast Spread | -352 -363 3.22% | -462 -472 2.02% | -391 -388 -0.86% | -595 -562 -5.81% | -737 -792 6.87% | -438 |
EBIT Million CHF | Released Forecast Spread | -371 -370 -0.18% | -482 -486 0.73% | -411 -412 0.21% | -613 -580 -5.65% | -757 -836 9.48% | -382 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -388 -386 -0.55% | -485 -482 -0.56% | -449 -442 -1.54% | -635 -609 -4.19% | -820 -868 5.49% | -476 |
Net income Million CHF | Released Forecast Spread | -386 -378 -2.24% | -494 -486 -1.56% | -445 -443 -0.5% | -635 -606 -4.78% | -828 -869 4.67% | -407 |
EPS CHF | Released Forecast Spread | -3,10 -2,69 -15.16% | -3,76 -3,60 -4.44% | -3,11 -3,02 -3.07% | -3,77 -3,65 -3.32% | -4,67 -4,78 2.31% | -2,07 |
Announcement Date | 07/02/19 | 06/02/20 | 04/02/21 | 08/02/22 | 07/02/23 | - |
Quarterly results
Fiscal Period | December | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 13,0 11,5 13.04% | 17,0 6,95 144.71% | 5,00 8,11 -38.36% | 5,00 9,64 -48.12% | 17,0 15,0 13.36% | 21,0 27,8 -24.41% | 54,0 37,5 44.03% | 21,0 31,5 -33.28% | 30,0 34,0 -11.78% | 80,0 18,4 335.16% | 18,1 | 15,4 | 155 | 26,6 | 34,6 |
EBITDA Million CHF | Released Forecast Spread | -118 -158 25.38% | -224 -203 -10.23% | -188 -190 1.31% | -207 -202 -2.4% | -189 -191 0.96% | -174 -231 24.38% | -193 -208 7.33% | -173 -183 5.58% | -37,0 | -189 | |||||
EBIT Million CHF | Released Forecast Spread | -234 -268 12.52% | -123 -176 30.11% | -228 -215 -5.91% | -193 -198 2.41% | -212 -214 0.96% | -193 -205 5.91% | -180 -239 24.7% | -198 -198 0% | -177 -192 7.77% | 231 -179 228.98% | -165 | 30,9 | 177 | -93,3 | -88,4 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -139 -189 26.5% | -253 -204 -23.79% | -196 -221 11.23% | -222 -226 1.58% | -216 -219 1.37% | -190 -245 22.42% | -212 -217 2.46% | -192 -198 3.23% | 225 -184 221.99% | -204 | |||||
Net income Million CHF | Released Forecast Spread | -223 -262 14.72% | -140 -181 22.52% | -252 -224 -12.46% | -198 -212 6.41% | -222 -219 -1.59% | -216 -210 -3.06% | -193 -261 26.03% | -212 -216 1.64% | -193 -204 5.18% | 224 -184 221.45% | -204 | ||||
EPS CHF | Released Forecast Spread | -1,34 -1,57 14.65% | -0,83 -1,08 23.41% | -1,46 -1,30 -12.42% | -1,12 -1,15 2.64% | -1,25 -1,25 -0.09% | -1,22 -1,21 -0.87% | -1,09 -1,37 20.7% | -1,19 -1,15 -3.52% | -1,08 -0,98 -10.35% | 0,96 -1,05 191.14% | -0,97 | -0,19 | 0,32 | -0,25 | -0,18 |
Announcement Date | 27/07/21 | 26/10/21 | 08/02/22 | 26/04/22 | 26/07/22 | 25/10/22 | 07/02/23 | 25/04/23 | 25/07/23 | 24/10/23 | - | - | - | - | - |
Past sector events for Idorsia Ltd
2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IDIA Stock
- Calendar Idorsia Ltd